We noted that Meng Jiang et al. [17] constructed a deep-learning model that could differentiate the four categories of BC (Luminal A, Lumina B, HER2+, and Triple-negative) based on key molecular biomarkers such as ER and PR. Here, ERBB2 is linked to breast cancer.